1 active not recruiting, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Radotinib: new trials by email Literature Review of Radotinib trials Research Report on Radotinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) Radotinib, Imatinib - Chronic Myeloid Leukemia, Chronic Phase | Phase 3 | Active not recruiting | Il-Yang Pharm. Co., Ltd. | 238 | 2018-12-28 | 2026-09-03 |
| Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients Imatinib, Radotinib - Leukemia, Leukemia, Myeloid | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 242 | 2011-08-01 | 2016-02-24 |
Leukemia, Myeloid, Chronic-Phase (2) · Bone Marrow Diseases (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid (1) · Philadelphia Chromosome (1)
China (1) · Indonesia (1) · Philippines (1) · South Korea (1) · Thailand (1)
Jiang Qian (1)